Maria Grazia Perrone

Selective COX-1 inhibition: A therapeutic target to be reconsidered.

M. Perrone, A. Scilimati, M G Perrone, 2010, Current medicinal chemistry.

Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges

S. Ferorelli, A. Scilimati, Morena Miciaccia, 2024, Cancers.

Analytical interference of Burosumab therapy on intact fibroblast growth factor 23 (iFGF23) measurements using an immunoassay: preliminary evaluation.

A. Scilimati, F. Di Serio, R. Lovero, 2024, Journal of immunoassay & immunochemistry.